Related Experiment Video
Updated: Oct 14, 2025
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Survival Response of Patients With Gastric Cancer Treated With Regional Arterial-Perfusion Chemotherapy Is Correlated
Y E Ma1, Xianxian Liang1, L I Liu2
1College of Medical Imaging, Xuzhou Medical University, Xuzhou, P.R. China.
Background/Aim:
The aim of the present study was to correlate the survival response to regional arterial-perfusion chemotherapy (RAPC) with Borrmann classification in patients with gastric cancer.
Patients And Methods:
The survival response of 270 patients with advanced gastric cancer treated with RAPC was analyzed and Borrmann classification of the tumors was retrospectively correlated to survival.
Results:
The median survival time of RAPC-treated patients with Borrmann type I/II was 53 months compared with 19 and 12 months for those with Borrmann type III and IV, respectively (p<0.001).
Conclusion:
Borrmann classification is a potential indicator to predict prognosis of patients with advanced gastric cancer treated with RAPC.
